Procept class action lawsuit filed
Analysis based on 6 articles · First reported Jul 24, 2026 · Last updated Jul 29, 2026
The lawsuit and related disclosures have already caused significant stock price declines, totaling over 44% across three events. Continued legal proceedings and potential financial penalties may further pressure Procept's stock and investor confidence.
A class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) by the Operating Engineers Construction Industry and Miscellaneous Pension Fund, represented by Robbins Geller Rudman & Dowd LLP LLP. The lawsuit alleges that Procept and certain executives made false and misleading statements regarding its handpiece sales and inventory practices. Specifically, it claims Procept used an undisclosed discount program to inflate sales, leading to excess field inventory of over 10,000 units. The stock price fell significantly after each of three earnings disclosures in 2025 and 2026. Investors who purchased Procept common stock between February 28, 2024 and February 25, 2026 have until September 22, 2026 to seek lead plaintiff status.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard